Company news

Cerus Corporation news in 2026

Cerus Corporation's news releases, calls and decks from 2026, newest first.

View company

Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026

October 19, 2026

Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting

October 14, 2026

Cerus Corporation Announces Second Quarter 2026 Financial Results

July 30, 2026

Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026

July 16, 2026

Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress

June 17, 2026

Cerus Corporation Closes New Debt Facility of Up to $110 Million

June 8, 2026

Bradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann Lucena

May 27, 2026

Cerus Corporation Announces First Quarter 2026 Financial Results

April 29, 2026

Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

April 27, 2026

Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

April 16, 2026

Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

March 16, 2026

Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

March 2, 2026

Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

February 20, 2026

Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

February 17, 2026

DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice

January 22, 2026

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook

January 10, 2026

Calls in 2026

Decks in 2026